Results summary | View all lists in L2L MDB | View all genes in C05A.profile.ud50 |
Up-regulated at 4 hr following treatment of peripheral blood mononuclear cells (PBMC) with BAY 50-4798, an IL-2 receptor agonist. enrichment: 3.35-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
202912_AT | ADM | G | D | X | E | C | S | adrenomedullin | |||||
213002_AT | MARCKS | myristoylated alanine-rich protein kinase C substrate | |||||||||||
202435_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
206115_AT | EGR3 | D | R | C | early growth response 3 | ||||||||
201627_S_AT | INSIG1 | G | insulin induced gene 1 | ||||||||||
218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
202679_AT | NPC1 | T | E | Nasopharyngeal carcinoma 1 | |||||||||
202436_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
220154_AT | DST | C | S | dystonin |